| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/16/2004 | WO2004089882A3 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
| 12/16/2004 | WO2004085442A3 New calix arene compounds, their process of preparation and their use, particularly as enzymatic mimes |
| 12/16/2004 | WO2004074309A8 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 12/16/2004 | WO2004026293A3 Hemiasterlin derivatives for treating resistant tumors |
| 12/16/2004 | WO2004010951A3 Method of treating tumors |
| 12/16/2004 | WO2003105908B1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 12/16/2004 | WO2003090684A8 Polymer compositions containing a macrocyclic triene compound |
| 12/16/2004 | WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency |
| 12/16/2004 | US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory |
| 12/16/2004 | US20040254376 Cyclic amidine derivative |
| 12/16/2004 | US20040254372 Poly(adenosine 5'-diphospho-ribose)polymerase (PARP) inhibitor; for treating or preventing neurological, genetic, autoimmune, nervous system, cardiovascular disorders, cancer; such as myocardial infarction, angina pectoris and cardiogenic shock |
| 12/16/2004 | US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254343 Crystals of N2-(N,N-dimethyl-L-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide with potent antitumor activity |
| 12/16/2004 | US20040254339 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 12/16/2004 | US20040254338 Melanin-concentrating hormone antagonists |
| 12/16/2004 | US20040254249 Nonsteroidal antiinflammatory agents |
| 12/16/2004 | US20040254240 Anti-cancer nitro- and thia-fatty acids |
| 12/16/2004 | US20040254221 Viricides; anticancer agents; antiarthritic agents |
| 12/16/2004 | US20040254217 Aniline derivatives, their manufacture and use as pharmaceutical agents |
| 12/16/2004 | US20040254216 Inhibitors of p38 |
| 12/16/2004 | US20040254214 7-Amido-isoindolyl compounds and their pharmaceutical uses |
| 12/16/2004 | US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/16/2004 | US20040254211 Alpha v integrin receptor antagonists |
| 12/16/2004 | US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/16/2004 | US20040254204 Bicyclic derivatives for the treatment of abnormal cell growth |
| 12/16/2004 | US20040254203 Methods and compositions utilizing quinazolinones |
| 12/16/2004 | US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants |
| 12/16/2004 | US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 12/16/2004 | US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 12/16/2004 | US20040254191 Antiinflammatory agents; autoimmune diseases; controlling tumor necrosis factor; immunosuppressants |
| 12/16/2004 | US20040254189 Jnk inhibitors |
| 12/16/2004 | US20040254186 Pyridylfurans and pyrroles as raf kinase inhibitors |
| 12/16/2004 | US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects |
| 12/16/2004 | US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 12/16/2004 | US20040254175 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 12/16/2004 | US20040254165 Vitiligo; skin cancer; control skin coloring |
| 12/16/2004 | US20040254151 Osteoporosis, bone cancer; antiarthritic agents;paget's disease; antiinflammatory agents |
| 12/16/2004 | US20040254149 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy |
| 12/16/2004 | US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 12/16/2004 | US20040254144 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma |
| 12/16/2004 | US20040254141 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents |
| 12/16/2004 | US20040254137 Nucleotide sequences; for therapy of bone disorders, chondrondysplasis; biodrug; activation caspase signaling cascade |
| 12/16/2004 | US20040254123 Using benzylidene ascorbate in mixture with carrier |
| 12/16/2004 | US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation |
| 12/16/2004 | US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents |
| 12/16/2004 | US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders |
| 12/16/2004 | US20040253722 Process for the maturation of dentritic cells and a vaccine |
| 12/16/2004 | US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/16/2004 | US20040253697 Nucleotide sequences coding epothilone polyketide synthase for use in generating fungicides, immunosuppressants and/or antitumor agents in microorganisms; bioreactors and heterologous gene expression |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253681 Mitogenic oxygenase regulators |
| 12/16/2004 | US20040253658 Monitoing novel kinase activity via change in adenosine triphosphate concentration and bioluminescence in presence of kinase and phosphorylatable substrate; bioassay |
| 12/16/2004 | US20040253653 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy |
| 12/16/2004 | US20040253651 Detected from secreted glycoprotein (such as matrix metalloproteinases, prostate specific antigen, kallikrein 2, human chorionic gonadotrophin or carcinoembryonic antigen); glycosyltransferases; for diagnosing and targeting cell proliferative disorders; vaccines |
| 12/16/2004 | US20040253646 Pre-mrna splicing screening assay |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253597 Sodium dependent dicarboxylate transport protein for use in identifying modulators for prevention/treatment of hepatic, prostate, splenic, renal diseases, metabolic, circulatory, cancer and aging disorders |
| 12/16/2004 | US20040253595 P53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253317 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma |
| 12/16/2004 | US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease |
| 12/16/2004 | US20040253239 nucleotide sequences that code angiogenic factor antagonists and vascular endothelial structure regulators, used for prevention of angoigenesis or cancer; gene therapy |
| 12/16/2004 | US20040253234 DNA sequences that code antibodies or fragments; genetic vectors and host cells transformed by the vector, used for diagnosis and prophylaxis of cancer |
| 12/16/2004 | US20040253233 genetic engineered chimeric and humanized antibodies obtained from murine monoclonal antibody P3 (MAb P3) and its antiidiotypic antibodies, used as antitumor agents |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253226 administering to the animals angiogenesis inhibitors comprising kallikreins such as prostate specific antigens (PSA), hydrolase enzymes homologs or fragments; prophylaxis of cancer, arthritis and vision defects |
| 12/16/2004 | US20040253216 Activated checkpoint therapy and methods of use thereof |
| 12/16/2004 | US20040253214 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 12/16/2004 | US20040253208 Interleukin-1 muteins useful as vaccine adjuvants |
| 12/16/2004 | US20040253206 etoposide; hydrophobic drug attached to amphiphilic ethylene glycol oligomer or polymer via hydrolyzable bond; improves ability to penetrate blood-brain barrier; bond hydrolyzes in vivo, freeing the fully bioactive drug; improves solubility of the drug in the bloodstream; drug delivery to CNS |
| 12/16/2004 | US20040253205 c-Kit kinase inhibitor |
| 12/16/2004 | US20040253182 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 12/16/2004 | US20040253181 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 12/16/2004 | DE10324496A1 Targetorientierte Chemotherapie von Tumoren der Sexualorgane Target-oriented chemotherapy of tumors of the sexual organs |
| 12/16/2004 | DE10324062A1 Pharmazeutischer Wirkstoff Active Pharmaceutical Ingredient |
| 12/16/2004 | DE10323759A1 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen Remedies for internal use, especially against cancer |
| 12/16/2004 | DE10323758A1 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen Remedies for internal use, especially against cancer |
| 12/16/2004 | DE10323345A1 Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren New Pyridopyrazine and their use as kinase inhibitors |
| 12/16/2004 | DE10323278A1 Gebrauchsfertige Gemcitabin-Lösungskonzentrate Ready gemcitabine solution concentrates |
| 12/16/2004 | CA2531569A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stemcell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transformation introducing the gene |
| 12/16/2004 | CA2528897A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 12/16/2004 | CA2528157A1 Cell-containing preparations |
| 12/16/2004 | CA2528136A1 Transfection agents |
| 12/16/2004 | CA2527984A1 Vascular endothelial growth factor fusion constructs and uses thereof |
| 12/16/2004 | CA2527814A1 Isoindolin-1-one compounds as kinase inhibitors |
| 12/16/2004 | CA2527793A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 12/16/2004 | CA2527779A1 3-substituted indoles and derivatives thereof as therapeutic agents |
| 12/16/2004 | CA2527576A1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity |
| 12/16/2004 | CA2527341A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 12/16/2004 | CA2526995A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same |
| 12/16/2004 | CA2526694A1 Amidino compounds as cysteine protease inhibitors |
| 12/16/2004 | CA2526638A1 Method of mitigating the adverse effects of il-2 |
| 12/16/2004 | CA2526509A1 Connective tissue growth factor antibodies |
| 12/16/2004 | CA2524910A1 Therapeutical composition containing dendritic cells and use thereof |
| 12/15/2004 | EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition |
| 12/15/2004 | EP1486504A1 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof |
| 12/15/2004 | EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels |